亚盛医药

17.38

0.0000

Volume:- -

Turnover:38.17M

Market Cap:1.49B

PE:- -

High:17.38

Open:17.38

Low:17.38

Close:17.38

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Ascentage Pharma Announces Closing of U.S. Initial Public Offering

GlobeNewswire

·

29 Jan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AAPGV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAPGV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPGV\",,,,,undefined,":{"symbol":"AAPGV","market":"US","secType":"STK","nameCN":"亚盛医药","latestPrice":17.38,"timestamp":1737752400000,"preClose":17.38,"halted":8,"volume":0,"delay":0,"floatShares":7325000,"shares":85988600,"eps":0,"marketStatus":"Closed Juneteenth National Independence Day","change":0,"latestTime":"01-24 16:00:00 EST","open":17.38,"high":17.38,"low":17.38,"amount":38170939.23419999,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750406400000},"marketStatusCode":7,"symbolChange":{"newSymbol":"AAPG","executeDate":"2025-01-27"},"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":17.38,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPGV\",,,,,undefined,":{"symbol":"AAPGV","floatShares":7325000,"roa":"--","roe":"--","lyrEps":0,"shares":85988600,"dividePrice":0,"high":17.38,"amplitude":0,"preClose":17.38,"low":17.38,"week52Low":16.5,"pbRate":"--","week52High":18,"institutionHeld":0,"latestPrice":17.38,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":17.38},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AAPGV\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPGV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507052544","title":"Ascentage Pharma Announces Closing of U.S. Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2507052544","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507052544?lang=en_us&edition=fundamental","pubTime":"2025-01-29 05:01","pubTimestamp":1738098060,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025  -- Ascentage Pharma   announced today the closing of its U.S. initial public offering of 7,325,000 American depositary shares , at a public offering price of $17.25 per ADS, before underwriting discounts and commissions. Each ADS represents four ordinary shares of Ascentage Pharma. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ascentage Pharma, was approximately $126.4 million. In addition, Ascentage Pharma has granted the underwriters a 30-day option to purchase up to an additional 1,098,750 ADSs at the initial public offering price, less underwriting discounts and commissions. The ADSs began trading on the Nasdaq Global Market on January 24, 2025.J.P. Morgan and Citigroup acted as joint book-running managers for the offering.Hogan Wan, Head of IR and StrategyAscentage PharmaHogan.Wan@ascentage.com+86 512 85557777","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ascentage-pharma-announces-closing-u-210100399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AAPG","AAPGV"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPGV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-27","symbol":"AAPGV","oldSymbol":"AAPGV","defaultRemindTime":1737988200000,"newSymbol":"AAPG","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1737954000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPGV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPGV\",market:\"US\",delay:false,,,undefined,":{}}}